Incannex Healthcare Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Incannex Healthcare Inc. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $6.67M, a 37.79% decline year-over-year.
- Incannex Healthcare Inc. stock issued during period, value, new issues for the quarter ending 2025-12-31 was $2.20M, a 807.85% increase year-over-year.
- Incannex Healthcare Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $69.47M.
- Incannex Healthcare Inc. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $36.70M.
- Incannex Healthcare Inc. stock issued during period, value, new issues for fiscal 2025 was $48.42M.
- Incannex Healthcare Inc. stock issued during period, value, new issues for fiscal 2023 was $8.83M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-03-31 | $6.67M 10-Q · filed 2026-05-15 | $115.04M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | $2.20M 10-Q · filed 2026-05-15 | $119.09M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-09-30 | $69.47M 10-Q · filed 2026-05-15 | $117.14M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-06-30 | $36.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | $48.42M 10-K · filed 2025-09-29 |
| 2025-03-31 | $10.73M 10-Q · filed 2026-05-15 | |
| 2024-12-31 | $242.00K 10-Q · filed 2026-05-15 | |
| 2023-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | $8.83M 10-K · filed 2024-09-30 |
| 2023-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B |